Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven

…, S Settatree, M Barrett, C Parker, V Martins… - Journal of clinical …, 2008 - ascopubs.org
Purpose Studies indicate that castration-resistant prostate cancer (CRPC) remains driven by
ligand-dependent androgen receptor (AR) signaling. To evaluate this, a trial of abiraterone …

NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis

…, F Boxall, W Aherne, M Rowlands, A Hayes, V Martins… - Cancer research, 2008 - AACR
We describe the biological properties of NVP-AUY922, a novel resorcinylic isoxazole amide
heat shock protein 90 (HSP90) inhibitor. NVP-AUY922 potently inhibits HSP90 (K d = 1.7 …

4, 5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer

…, K James, AM Jordan, A Lockie, V Martins… - Journal of medicinal …, 2008 - ACS Publications
Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as
potential chemotherapeutic agents for cancer. Here, we describe the structure-based design, …

[HTML][HTML] Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received …

…, P Kantoff, F Raynaud, V Martins… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Abiraterone acetate is a prodrug of abiraterone, a selective inhibitor of CYP17, the
enzyme catalyst for two essential steps in androgen biosynthesis. In castration-resistant …

Light olefins/paraffins separation with 13X zeolite binderless beads

G Narin, VFD Martins, M Campo, AM Ribeiro… - Separation and …, 2014 - Elsevier
In this work 13X zeolite binderless beads were tested as a new promising material for
polymer-grade olefin production from olefin/paraffin mixtures by VPSA technology. In order to …

Fragment-based drug discovery targeting inhibitor of apoptosis proteins: discovery of a non-alanine lead series with dual activity against cIAP1 and XIAP

…, A Iqbal, CN Johnson, EJ Lewis, V Martins… - Journal of medicinal …, 2015 - ACS Publications
Inhibitor of apoptosis proteins (IAPs) are important regulators of apoptosis and pro-survival
signaling pathways whose deregulation is often associated with tumor genesis and tumor …

Ethane/ethylene separation on a copper benzene-1, 3, 5-tricarboxylate MOF

VFD Martins, AM Ribeiro, A Ferreira, UH Lee… - Separation and …, 2015 - Elsevier
The search for novel and more economical ways to separate olefins and paraffins by adsorptive
processes has motivated the appearance of improved materials. Recently, metal organic …

Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical …

…, M Matteucci, NE Wilsher, V Martins… - Journal of medicinal …, 2010 - ACS Publications
Lead optimization studies using 7 as the starting point led to a new class of imidazo[4,5-b]pyridine-based
inhibitors of Aurora kinases that possessed the 1-benzylpiperazinyl motif at the …

AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity

…, MR Valenti, AK de Haven Brandon, V Martins… - Clinical cancer …, 2012 - AACR
Purpose: Deregulated phosphatidylinositol 3-kinase pathway signaling through AGC kinases
including AKT, p70S6 kinase, PKA, SGK and Rho kinase is a key driver of multiple cancers…

[HTML][HTML] Sieving di-branched from mono-branched and linear alkanes using ZIF-8: experimental proof and theoretical explanation

…, MA Granato, VFD Martins… - Physical Chemistry …, 2013 - pubs.rsc.org
We study the adsorption equilibrium isotherms and differential heats of adsorption of hexane
isomers on the zeolitic imidazolate framework ZIF-8. The studies are carried out at 373 K …